Robert F. Kennedy Jr. criticized Ozempic, suggesting that providing healthy food to all Americans could immediately address obesity and diabetes, blaming drug company profits for the epidemic.
Kennedy implied that Novo Nordisk exploits the public's reliance on medication, arguing that the pharmaceutical industry takes advantage of societal issues rather than addressing the root causes.
Despite his criticisms, it remains unclear how Kennedy would use his potential position at the Department of Health and Human Services regarding obesity drugs like Ozempic.
FDA's procedures require strong evidence for drug withdrawal, including safety and efficacy concerns, and are not directly influenced by the Secretary of Health and Human Services.
Collection
[
|
...
]